News
Orforglipron: What to Know About Eli Lilly’s New Weight Loss Pill for Obesity
Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials. The weight loss pill also significantly improved heart health markers like cholesterol and blood pressure.
Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its debut in Africa ...
The federal government just reached a settlement with one company after investigators say it used deceptive claims and fake ...
New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an increased risk of rare eye conditions.
The Hunting Wives' actress Chrissy Metz gets candid in a new cover story for PEOPLE on her thoughts about using weight loss ...
Weight-loss drugs significantly improve health, though they’re also tied to increased spending on other medical care that’s ...
One study found a modest risk of developing non-arteritic anterior ischaemic optic neuropathy (NAOIN), a rare eye condition ...
Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight off, but ...
16hon MSN
Rosie O'Donnell Calls Weight Loss Drug Mounjaro A 'Life Saver' As She Celebrates Being A Size 12
Rosie O'Donnell has revealed that she’s now a size 12 thanks to Mounjaro, healthier eating, and lifestyle changes like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback